Insulet Corporation Receivables Turnover Ratio (PODD), from the third quarter 2026 to the third quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Insulet Corporation  (NASDAQ: PODD)
 

Insulet Accounts Receivables Turnover Ratio from the third quarter 2026 to the third quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Insulet Corporation's ability to collect accounts receivable sequentially worsen to 5.45, pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Insulet's Accounts Receivable average collection period in the Sep 30 2026 quarter, has increased to 67 days, from 58 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 278 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2026 from 1172 to 1876.

What is Receivable Turnover Ratio?
What is Insulet Corporation Selling?


What is Receivable Turnover Ratio?





PODD Receivables Turnover Ratio (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Receivable Change 124.8 % 92.13 % 92.41 % 104.71 % 17.12 %
Y / Y Revenue Change 19.21 % 23.51 % 33.87 % 31.16 % 29.86 %
Receivable Turnover Ratio (TTM) 5.45 6.24 6.93 7.67 8.78
PODD's Total Ranking # 1876 # 1172 # 454 # 813 #
Accounts Receivable average collection period days 67 58 53 48 42
Seq. Receivable Change 17.04 % 8.08 % 5.38 % 68.65 % 0.03 %
Seq. Revenue Change 5.03 % 5.25 % -2.81 % 10.96 % 8.81 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 106
Healthcare Sector # 279
Overall Market # 1876

Receivable Turnover Ratio Statistics
High Average Low
11.32 8.79 6.15
(Sep 30 2017)   (Mar 31 2015)




  News about Insulet Corporation Receivables Turnover Ratios

Insulet Expands Reach with Launch of Omnipod 5 in Europe Amid Financial Challenges

In a significant advancement for diabetes management, Insulet Corporation, a pioneer in tubeless insulin pump technology headquartered in Acton, Massachusetts, has announced the commercial launch of its revolutionary Omnipod 5 Automated Insulin Delivery System in five additional countries across Europe: Italy, Denmark, Finland, Norway, and Sweden. This move marks another step in Insulet s mission to provide innovative diabetes care solutions to patients globally.The Omnipod 5 system, designed to simplify insulin delivery, enhances patient convenience and lifestyle integration. Notably, the new system is compatible with both Abbott s FreeStyle Libre 2 Plus and Dexcom G6 Continuous Glucose Monitoring (CGM) sensors, allowing users to maintain more precise control over their blood glucose levels. This compatibility is expected to facilitate better management of diabetes for users in the newly added European markets, thereby improving their quality of life.




Financial Statements
Insulet's Accounts Receivable $ 689 Millions Visit PODD's Balance sheet
Insulet's Sales TTM $ 3,189 Millions Visit PODD's Income Statement
Sources of PODD's Revenues Visit PODD's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PODD's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PODD's Growth Rates PODD's Roa PODD's Inventory Turnover Ratio PODD's Dividend Comparisons
PODD's Profitability Ratios PODD's Roi PODD's Asset Turnover Ratio PODD's Dividend Growth
PODD's Valuation Ratios PODD's Roe PODD's Financial Strength Ratios PODD's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Receivable at quarter ending Sep 30 2026
Chemed Corporation  12.65 $ 2,661.041  Millions$ 210.387  Millions
Caredx Inc   11.75 $ 497.396  Millions$ 42.330  Millions
Teladoc Health Inc   11.50 $ 2,468.143  Millions$ 214.604  Millions
Iqvia Holdings Inc   10.43 $ 17,311.000  Millions$ 1,659.500  Millions
Encompass Health Corporation  9.41 $ 6,338.100  Millions$ 673.625  Millions
Bausch Health Companies Inc   9.15 $ 11,113.000  Millions$ 1,215.000  Millions
Pacs Group Inc   8.88 $ 5,705.049  Millions$ 642.729  Millions
Axogen inc   8.71 $ 266.926  Millions$ 30.654  Millions
Ensign Group Inc  8.62 $ 5,674.305  Millions$ 658.477  Millions
Pediatrix Medical Group Inc   8.57 $ 1,959.124  Millions$ 228.471  Millions
Tenet Healthcare Corp  8.54 $ 22,154.000  Millions$ 2,593.250  Millions
Brightspring Health Services Inc   8.50 $ 9,479.144  Millions$ 1,114.763  Millions
Sotera Health Company  8.49 $ 1,230.250  Millions$ 144.974  Millions
Tactile Systems Technology Inc   8.23 $ 357.176  Millions$ 43.385  Millions
Penumbra Inc  8.22 $ 1,560.334  Millions$ 189.735  Millions
Inspire Medical Systems inc   8.15 $ 882.194  Millions$ 108.207  Millions
Adapthealth Corp   8.14 $ 3,152.043  Millions$ 387.280  Millions
Rhythm Pharmaceuticals Inc   8.03 $ 280.748  Millions$ 34.950  Millions
Alphatec Holdings Inc   7.91 $ 839.652  Millions$ 106.153  Millions
Exelixis Inc   7.89 $ 2,496.861  Millions$ 316.636  Millions
Henry Schein Inc   7.84 $ 13,734.000  Millions$ 1,752.000  Millions
Idexx Laboratories Inc  7.78 $ 4,663.675  Millions$ 599.701  Millions
Madrigal Pharmaceuticals Inc   7.70 $ 1,427.940  Millions$ 185.380  Millions
Pulmonx Corporation  7.56 $ 89.176  Millions$ 11.791  Millions
Merit Medical Systems Inc  7.53 $ 1,612.236  Millions$ 214.065  Millions
Cerus Corporation  7.48 $ 226.798  Millions$ 30.308  Millions
Insmed Inc  7.45 $ 1,479.040  Millions$ 198.502  Millions
Novocure Limited  7.44 $ 725.388  Millions$ 97.525  Millions
Intuitive Surgical Inc   7.44 $ 12,115.600  Millions$ 1,629.350  Millions
Quest Diagnostics Inc  7.43 $ 11,841.000  Millions$ 1,593.250  Millions

Date modified: 2026-11-06T12:56:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.